SEC Company Response from AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702) (FFR) — Nov 28, 2018

AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)
Date: Nov. 28, 2018 · CIK: 0001460702 · Accession: 0001493152-18-016830

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-228501

Date

Nov. 28, 2018

Author

Chief

Form

CORRESP

Company

AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)

Letter

VIA EDGAR United States Securities and Exchange Commission Attention: Christine Westbrook Re: Ritter Pharmaceuticals, Inc. – Request for Acceleration Registration Statement on Form S-3 File No. 333-228501

Dear Ms. Yale:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Ritter Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-228501) (the “Registration Statement”), so that it may become effective at 5:00 p.m. Eastern Standard Time on Friday, November 30, 2018, or as soon thereafter as practicable.

The Registrant hereby authorizes each of Aron Izower, Esq. and Wendy Grasso, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Aron Izower at (212) 549-0393 or, in his absence, Wendy Grasso at (212) 549-0216.

RITTER PHARMACEUTICALS, INC.

/s/ John W. Beck

By: John W. Beck

Chief Financial Officer

Show Raw Text

CORRESP
1
filename1.htm

1880
Century Park East

Suite
1000

Los
Angeles, California 90067

(310)
203-1000

November
29, 2018

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, NE

Washington,
D.C. 20549

Attention:
Christine Westbrook

    Re:

    Ritter
    Pharmaceuticals, Inc. – Request for Acceleration

    Registration
    Statement on Form S-3

    File
    No. 333-228501

Dear
Ms. Yale:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, Ritter Pharmaceuticals, Inc. (the “Registrant”)
hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-228501) (the “Registration
Statement”), so that it may become effective at 5:00 p.m. Eastern Standard Time on Friday, November 30, 2018, or
as soon thereafter as practicable.

The
Registrant hereby authorizes each of Aron Izower, Esq. and Wendy Grasso, Esq. of Reed Smith LLP, attorneys for the Registrant,
to orally modify or withdraw this request for acceleration.

The
Registrant requests that it be notified of such effectiveness by a telephone call to Aron Izower at (212) 549-0393 or, in his
absence, Wendy Grasso at (212) 549-0216.

    RITTER PHARMACEUTICALS, INC.

    /s/
    John W. Beck

    By:
    John
    W. Beck

    Chief
    Financial Officer

SecProbe.io